Large-scale testing (Phase 3)Study completedNCT01064414
What this trial is testing
An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Janssen Research & Development, LLC 272